Podcasts

Jeff Stoll, US Life Sciences Strategy Leader at KPM, talks about some of the highlights from KPMG’s recent Global Pharma CEO Outlook report.

Amie Krause, Senior Vice President and Chief People Officer, and Kristin Yarema, Chief Commercial Officer, of Atara Biotherapeutics, talk about gender diversity in the c-suite and how that can benefit a company both internally and externally.

Michael Petroutsas, Senior Vice President and Head of GSK’s US Oncology Business Unit, talks about how his background has taught him the importance of connecting with patients on their level and how he brings that mentality to GSK.

Go beyond the hype of digital transformation and learn its true promise. With advanced analytics in your pharma labs, you can transform all your data into actionable scientific and business insights that lead to better outcomes. LabVantage Solutions is working with pharmaceutical companies worldwide to integrate their labs with their enterprise digital ecosystems. Find out how LabVantage’s informatics platform, complete with AI-powered, self-service analytics, is making a difference across the pharmaceutical industry.

Tom McCourt, CEO of Ironwood Pharmaceuticals, talks about his 30-plus years in the gastrointestinal space, including his experiences bringing top GI medicines Prilosec, Nexium, Entocort, Zelnorm, and Linzess to market.

Dr. Michael Henderson, chief business officer of BridgeBio Pharma, and one of Pharm Exec’s 2021 Emerging Pharma Leaders, discusses how his company goes beyond the traditional “hand off” approach between academia and industry, and looks to partner with institutions early on to fill important voids in drug development.

In Episode Two of the Syneos Health Dedicated Dialogue podcast series, we reveal how harnessing broad expertise across the product development lifecycle leads to relevant, effective and efficient solutions that speed commercial success and bring novel drugs to patients sooner to improve patient care.

Dr. Edith Perez, Chief Medical Officer of Bolt Biotherapeutics, discusses how she approaches drug development in oncology, and what she contributes outside of work to help raise awareness for cancer.

Audrey Greenberg, co-founder and executive managing director of the Center for Breakthrough Medicines and Discovery Labs, discusses how cell and gene therapy has turned Philadelphia into Cellicon Valley, and how her organization is playing a role in that growth even beyond the city’s borders.

In Episode One of the Syneos Health Dedicated Dialogue podcast series, we discuss how harnessing the drivers of modern customer engagement informs decisions in product development, leading to enhanced experiences for patients and healthcare providers from lab to life.

Yan Chen, CEO of Elpis Biopharmaceuticals, talks about how she transitioned her career from scientist to CEO and what that has entailed.

Arthur Kuan, CEO of CG Oncology, talks about the present and future of bladder cancer therapies, and how he’s committed to making a difference.

Cherie Davies, SVP, Executive Creative Director at FCB Chicago, talks about inspiring award-winning creative, especially in COVID times.

Learn how Frontage Laboratories started, recent growth and expansion, and the future vision of Frontage

Emma Chaffin, vice president and country head of Galapagos UK, discusses how her personal journey with cancer put a spin on her life, including her career in pharma.

Teresa Bitetti, President of Takeda Pharmaceuticals’ Global Oncology Business Unit, talks about her experience as a leader in the oncology space and what that entails in today’s environment.

Judy Stewart, head of US vaccines at GSK, talks about the effects of people missing their recommended vaccinations during the pandemic and the importance of delivering a message of value for vaccines.

Tina and Kathy Delaney, CCO of Publicis Health/Saatchi Wellness, chat about creative inspiration, trends and surreal career moments.

Mike Starich, CEO of Orion Talent, and Dr. Armand Balboni, CEO of Appili Therapeutics, talk about hiring veterans for roles in pharma, and how the industry can capitalize on their unique qualifications.

Darrell Wakefield, Franchise Head, Solid Tumor, Sanofi Genzyme, talks creative impact on brand success.

Our editorial team presents the winners of our annual Emerging Pharma Leaders and their up-and-coming perspectives on a range of industry topics.

Sandor Schoichet, an independent advisor and director of Meridian Management Consultants based in San Francisco, and Thomas Scheiwiller, an independent advisor and board member based in Zurich, talk about integrating environmental, social, and governance, or ESG, issues into biopharma business planning, and communicating with capital investors about these areas.

Shaheed Peera, President, Founder and CEO of The Creative Floor Awards, London, and Global Creative Lead for Reckitt Benckiser ECom, talks about inspiring award-winning creative, reflects on his time as President on Cannes, and provides some insight on his award show The Creative Floor as well as a few tips about the inaugural PharmExec APEX Awards

Dr. Michele Cleary, CEO of the Mark Foundation for Cancer Research, discusses how the foundation has navigated COVID to help keep critical cancer research going throughout the pandemic.

John Furey, CEO of Imvax and an Editorial Advisory Board member for Pharm Exec, discusses some leadership principles he learned while playing rugby as a young man in Ireland, and how those tenets can translate to the C-suite.

Uche Iloeje, Vice President medical affairs Mirdametenib at SpringWorks Therapeutics, shares his experience after he became stranded in Nigeria for five months and the valuable leadership lessons he learned.

Paul Shawah, Executive Vice President of Strategy at Veeva Systems, looks back at the past year of the pandemic to see the digital transformation of pharma’s interaction with healthcare professionals.

Kevin Buckley, founder of Torrey Pines Law Group, and Neil Thompson, a patent agent with the firm, discuss IP strategy as it relates to pharma and artificial intelligence.

Omnichannel marketing bridges the gap from marketing operations to sales excellence. A well-planned, omnichannel marketing strategy allows pharma companies to reach the right people, at the right time, with the right message. Omnichannel marketing provides a holistic view of the customer to improve stakeholder experience across all touchpoints.

Joel Marcus, founder and executive chairman of Alexandria Real Estate Equities, and founder and CEO of Alexandria Venture Investments, talks about the effects of COVID on worldwide biomanufacturing, and what the repatriation of pharma could look like.